Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.08 – $0.08
Exchange
OTC Link
ADRC
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.7M | $7.4M | $3.9M | $6.1M | $8.0M | $7.4M | $9.4M | $12.5M |
| Cost of revenue | $3.8M | $3.9M | $2.3M | $3.4M | $4.1M | $4.1M | $5.3M | $5.6M |
| Gross profit | $2.9M | $3.5M | $1.6M | $2.7M | $3.9M | $3.3M | $4.1M | $6.9M |
| Gross margin | 43.8% | 46.7% | 41.0% | 44.7% | 48.7% | 44.6% | 43.6% | 55.3% |
| R&D | $810.0K | $738.0K | $779.0K | $678.0K | $1.2M | $541.0K | $467.0K | $329.5K |
| Operating income | −$5.2M | −$3.6M | −$3.4M | −$4.4M | −$4.0M | −$6.4M | −$4.9M | −$3.9M |
| EBITDA | −$4.4M | −$2.2M | −$3.1M | −$3.6M | −$3.2M | −$5.1M | −$3.8M | −$3.7M |
| Net income | −$5.6M | −$3.6M | −$4.0M | −$3.1M | −$3.5M | −$6.7M | −$4.4M | −$4.4M |
| Net margin | -82.6% | -49.2% | -102.2% | -50.3% | -44.1% | -89.6% | -46.4% | -35.1% |
| EPS (diluted) | -0.37 | -0.15 | -0.06 | -0.03 | -0.01 | -0.01 | -0.00 | -0.00 |
Annual figures · source: Financial Modeling Prep
IMPLANET SA SPNS/ADR
No one on the platform currently holds IMPZY.
No tracked institution reports a position in IMPZY as of their last filing.
No one on the platform has traded IMPZY yet.
| $212M |
| — |
| RCELAvita Medical Inc. | $4.01 | -5.65% | $100M | — |
| SHIEFShield Therapeutics plc | $0.08 | +0.00% | $86M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.